TCI Wealth Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-114
| Closed | -$3K | – | 2317 |
|
2022
Q2 | $3K | Sell |
114
-182
| -61% | -$4.79K | ﹤0.01% | 1776 |
|
2022
Q1 | $10K | Buy |
296
+80
| +37% | +$2.7K | ﹤0.01% | 1085 |
|
2021
Q4 | $10K | Buy |
216
+59
| +38% | +$2.73K | ﹤0.01% | 1152 |
|
2021
Q3 | $8K | Buy |
157
+80
| +104% | +$4.08K | ﹤0.01% | 1224 |
|
2021
Q2 | $6K | Buy |
77
+11
| +17% | +$857 | ﹤0.01% | 1278 |
|
2021
Q1 | $4K | Buy |
+66
| New | +$4K | ﹤0.01% | 1334 |
|